Back to search

Deciphera Pharmaceuticals (Uk) Limited

12593299

active
Private Limited Company
Companies House
Health Score
80 / 100

Healthy

30/30
Filing
10/30
Financial
40/40
Risk
  • Current liabilities exceed current assets (-10)

Details

SUITE 2, GROUND FLOOR, BRISTOL, BS1 6FL
Incorporated 11/05/2020

Compliance

Accounts

Up to date

Confirmation statement

Up to date

Industry

82990
Other business support service activities

Officers

Maria Ostrovsky

director · Since 16/12/2024

LAWYER

AMERICAN · UNITED STATES · Age 46

Former

Jennifer Larson

director · Resigned 15/08/2026

Persons with Significant Control

Deciphera Pharmaceuticals, Inc

50–75% shares
50–75% votes
Appoint directors

200, Smith Street, Massachussets, 02451

Reg: 6497832 · Delaware Register Of Companies · Public Company With Limited Liability

Notified 23/11/2020

Former PSCs

Deciphera Pharmaceuticals Llc

Ceased 23/11/2020

CompanyRankvs 101145+ SIC 82990 peers
47

Financial strength27th percentile among SIC peers · 7/25
Employees88th percentile among SIC peers · 13/15
LiquidityCurrent ratio 1× · 6/20
Longevity6 years trading (max 15) · 6/15
Filing complianceAll filings up to date · 15/15
Show leaderboard
How is this score calculated?
Financial strength7/25 pts

Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.

Employees13/15 pts

Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.

Liquidity6/20 pts

Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.

Longevity6/15 pts

One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.

Filing compliance15/15 pts

Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.

Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.

Key FinancialsYear ending 31/03/2026

Net Worth

£2

Balance sheet strength

Cash

£782k

Cash in the bank

Net Current Assets

-£404

Working capital

Current Assets

£791k

Current Liabilities

£791k

Debtors

£8k

4avg. employees+1

Balance Sheet

Assets less current liabilities-£399
Prepared with IRIS Accounts Production

EstimatesDerived

YearCurrent Ratio
20261.00
20250.98

Derived from filed accounts. Not audited figures.